GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Neuromeka Co Ltd (XKRX:348340) » Definitions » EBIT

Neuromeka Co (XKRX:348340) EBIT : ₩-17,187 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Neuromeka Co EBIT?

Neuromeka Co's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2024 was ₩-2,668 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-17,187 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Neuromeka Co's annualized ROC % for the quarter that ended in Dec. 2024 was -15.24%. Neuromeka Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -46.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Neuromeka Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -5.67%.


Neuromeka Co EBIT Historical Data

The historical data trend for Neuromeka Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuromeka Co EBIT Chart

Neuromeka Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial -7,789.70 -6,061.33 -7,908.59 -15,595.97 -11,795.65

Neuromeka Co Quarterly Data
Jun21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7,858.93 -4,542.52 -4,298.98 -5,677.47 -2,667.62

Competitive Comparison of Neuromeka Co's EBIT

For the Specialty Industrial Machinery subindustry, Neuromeka Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuromeka Co's EV-to-EBIT Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Neuromeka Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Neuromeka Co's EV-to-EBIT falls into.


;
;

Neuromeka Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-17,187 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neuromeka Co  (XKRX:348340) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Neuromeka Co's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=-15061.552 * ( 1 - -0.62% )/( (91578.823 + 107282.422)/ 2 )
=-15154.9336224/99430.6225
=-15.24 %

where

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=83408.308 - 4245.47 - ( 14321.357 - max(0, 48729.173 - 36313.188+14321.357))
=91578.823

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=95229.547 - 3808.571 - ( 20035.106 - max(0, 58241.461 - 42380.015+20035.106))
=107282.422

Note: The Operating Income data used here is four times the quarterly (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Neuromeka Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-10670.464/( ( (20525.883 + max(-7198.544, 0)) + (25871.146 + max(-9623.868, 0)) )/ 2 )
=-10670.464/( ( 20525.883 + 25871.146 )/ 2 )
=-10670.464/23198.5145
=-46.00 %

where Working Capital is:

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(9441.55 + 5541.737 + 3433.884) - (4245.47 + 0 + 21370.245)
=-7198.544

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6164.454 + 7919.971 + 5024.704) - (3808.571 + 0 + 24924.426)
=-9623.868

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Neuromeka Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=-17186.587/303122.916
=-5.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neuromeka Co EBIT Related Terms

Thank you for viewing the detailed overview of Neuromeka Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Neuromeka Co Business Description

Traded in Other Exchanges
N/A
Address
7 Yeonmujang 5-ga-gil, 15th floor, Hyundai Terrace Tower, W Building, Seongdong-gu, Seoul, KOR, 04782
Neuromeka Co Ltd is a robot company. It is building a robot as a service platform business ecosystem centered on collaborative robots so that even small and medium-sized manufacturing companies without robot experts can introduce and operate robot automation without burden.

Neuromeka Co Headlines

No Headlines